Urologic Diseases  >>  cyclosporine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

9 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00005113: A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant

Terminated
3
102
US
Cyclosporine, CsA, Sirolimus, SRL, Tacrolimus
Boston Children's Hospital
End-Stage Renal Disease, Kidney Transplantation
07/04
03/06
NCT00273871: Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients

Completed
3
190
Europe
Cyclosporin or tacrolimus
Wyeth is now a wholly owned subsidiary of Pfizer
Graft Rejection, Kidney Failure, Kidney Transplantation
 
09/06
NCT00167947: Study Evaluating Sirolimus in Kidney Transplant Recipients.

Completed
3
150
Europe
Cyclosporine, Steroids, Rapamune (Sirolimus)
Wyeth is now a wholly owned subsidiary of Pfizer
Kidney Failure, Graft vs Host Disease
07/07
07/07
NCT00248313: Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus

Completed
3
470
RoW
Rapamune®
Wyeth is now a wholly owned subsidiary of Pfizer
Kidney Disease
 
10/07
NCT00309218: Steroid Withdrawal in Pediatric Renal Transplant Recipients Under Cyclosporine (CyA) and Mycophenolate Mofetil (MMF)

Completed
3
42
Europe
methylprednisolone
Klinik für Kinder- und Jugendmedizin, Hoffmann-La Roche
Kidney Diseases
06/08
06/08
BENEFIT, NCT00256750 / 2004-003635-31: Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression

Checkmark ESOT 2015
Aug 2015 - Aug 2015: ESOT 2015
Checkmark ESOT 2015
Aug 2015 - Aug 2015: ESOT 2015
Checkmark ESOT 2015
More
Completed
3
738
US, Canada, Europe, RoW
Cyclosporine (CsA), Belatacept LI (less intensive), Belatacept MI (more intensive)
Bristol-Myers Squibb
Kidney Transplantation, Chronic Kidney Failure
06/08
04/15
NCT00135811: Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)

Completed
3
207
US
Cyclosporin, MMF and Dexamethasone
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The Cleveland Clinic
Glomerulosclerosis, Focal
10/09
10/09
Csa-LES, NCT01299922: Clinical Trial Treatment in Lupus Nephritis

Withdrawn
3
0
Europe
cyclosporine +mycophenolic acid+prednison, Triple therapy, Mycophenolic Acid + prednison, Conventional therapy
Hospital Universitario Fundación Alcorcón, Hospital Universitario 12 de Octubre, Hospital General Universitario Gregorio Marañon, Hospital Universitario Ramon y Cajal, Hospital Infanta Sofia, Hospital Universitario Infanta Leonor, Hospital Universitario Reina Sofia de Cordoba, Hospital Regional Universitario Carlos Haya, Hospital Universitario Virgen de la Victoria, University Hospital of the Nuestra Señora de Candelaria, Hospital Universitario de Guadalajara. Spain, Hospital San Pedro de Alcantara, Hospital Juan Canalejo
Lupus Nephritis
03/14
10/14
MENTOR, NCT01180036: MEmbranous Nephropathy Trial Of Rituximab

Completed
2/3
130
Canada, US
Rituximab, Rituxan, MabThera, Cyclosporine, Sandimmune
Mayo Clinic, Columbia University, University of British Columbia, Ohio State University, Stanford University, University of Washington, University of Michigan, University of Alabama at Birmingham, Case Western Reserve University, The Cleveland Clinic, University of Kansas Medical Center, University of Manchester, University Health Network, Toronto, University of Toronto, CHU de Quebec-Universite Laval, Washington University School of Medicine, Florida International University, University of Mississippi Medical Center, NYU Langone Health, Medical College of Wisconsin, University of Arizona, Sunnybrook Health Sciences Centre, Applied Health Research Centre, Fulk Family Foundation
Idiopathic Membranous Nephropathy
10/17
10/17

Download Options